XJPX2664
Market cap356mUSD
Jan 14, Last price
2,526.00JPY
1D
0.32%
1Q
-2.70%
Jan 2017
-13.34%
Name
Cawachi Ltd
Chart & Performance
Profile
Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance business. The company operates 355 drugstores. Cawachi Limited was founded in 1967 and is headquartered in Oyama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 285,960,000 1.45% | 281,871,000 0.86% | 279,462,000 -1.77% | |||||||
Cost of revenue | 220,158,000 | 217,824,000 | 216,313,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 65,802,000 | 64,047,000 | 63,149,000 | |||||||
NOPBT Margin | 23.01% | 22.72% | 22.60% | |||||||
Operating Taxes | 2,440,000 | 2,394,000 | 2,857,000 | |||||||
Tax Rate | 3.71% | 3.74% | 4.52% | |||||||
NOPAT | 63,362,000 | 61,653,000 | 60,292,000 | |||||||
Net income | 4,713,000 12.83% | 4,177,000 -13.52% | 4,830,000 -32.06% | |||||||
Dividends | (1,116,000) | (1,116,000) | (1,115,000) | |||||||
Dividend yield | 1.88% | 2.18% | 2.22% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 6,706,000 | 7,909,000 | 9,200,000 | |||||||
Long-term debt | 10,023,000 | 11,640,000 | 13,719,000 | |||||||
Deferred revenue | (743,000) | (756,000) | ||||||||
Other long-term liabilities | 13,127,000 | 12,697,000 | 12,688,000 | |||||||
Net debt | (26,796,000) | (26,958,000) | (24,301,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 6,402,000 | 9,817,000 | 6,868,000 | |||||||
CAPEX | (4,835,000) | (5,707,000) | (4,499,000) | |||||||
Cash from investing activities | (5,291,000) | (5,840,000) | (4,536,000) | |||||||
Cash from financing activities | (3,937,000) | (4,485,000) | (4,607,000) | |||||||
FCF | 71,846,000 | 53,501,000 | 61,349,000 | |||||||
Balance | ||||||||||
Cash | 35,623,000 | 38,450,000 | 38,959,000 | |||||||
Long term investments | 7,902,000 | 8,057,000 | 8,261,000 | |||||||
Excess cash | 29,227,000 | 32,413,450 | 33,246,900 | |||||||
Stockholders' equity | 100,753,000 | 204,795,000 | 198,658,000 | |||||||
Invested Capital | 111,923,000 | 105,389,550 | 105,036,100 | |||||||
ROIC | 58.31% | 58.60% | 58.80% | |||||||
ROCE | 46.62% | 46.23% | 45.42% | |||||||
EV | ||||||||||
Common stock shares outstanding | 22,359 | 22,360 | 22,357 | |||||||
Price | 2,656.00 16.13% | 2,287.00 1.78% | 2,247.00 -22.01% | |||||||
Market cap | 59,386,728 16.13% | 51,136,222 1.79% | 50,236,716 -21.88% | |||||||
EV | 32,590,728 | 131,789,222 | 130,458,716 | |||||||
EBITDA | 70,108,000 | 68,397,000 | 67,573,000 | |||||||
EV/EBITDA | 0.46 | 1.93 | 1.93 | |||||||
Interest | 35,000 | 41,000 | 49,000 | |||||||
Interest/NOPBT | 0.05% | 0.06% | 0.08% |